Revvity stock heads into the open after a 9.1% jump

At the close on September 16, 2026, Revvity stock finished at USD 140.19 on the New York Stock Exchange, up 9.1% and nearly matching its 52-week high. The move outpaced the Nasdaq’s advance and leaves the shares just below their recent peak ahead of today’s session.

Revvity stock closed at USD 140.19 on the New York Stock Exchange on September 16, 2026, gaining 9.1% versus the prior session and finishing essentially at its 52-week high of USD 140.21. The advance exceeded the rise in the technology-heavy Nasdaq index that day, underscoring the stock’s strong momentum heading into today’s US session.

September 16, 2026 in numbers

Revvity Inc. (ISIN US76155R1086) saw its shares rally on September 16, 2026, as they climbed to a close of USD 140.19 on the New York Stock Exchange, up 9.1% from the previous trading day and almost exactly at the 52-week high of USD 140.21 reported for the stock. According to Ad-hoc-news, this latest move extended an earlier rally that had already carried the shares to a fresh 52-week high, signaling sustained investor demand. The closing level left the stock fractionally below that high, highlighting how tightly it is trading to the top of its recent range.

Per market data cited in the same report from Ad-hoc-news, Revvity’s performance on September 16, 2026 was supported by a firm broader market backdrop, with the benchmark S and P 500 index also advancing that day. The stock’s 9.1% gain, however, substantially outpaced the index move, indicating that company-specific factors and positioning in the health and diagnostics space may be contributing to the outperformance, even as the exact catalyst for the single-session jump was not detailed in the report.

Today’s drivers and upcoming dates

Heading into today’s US session on September 18, 2026, investors in Revvity are watching for further company communications and sector signals, particularly after the shares brushed against their 52-week high earlier this week. The company’s 2025 annual report, available through Sustainabilityreports.com, provides the fundamental backdrop that many market participants are using to assess the sustainability of the recent rally, but no specific earnings release or scheduled corporate event for September 18, 2026 is highlighted there. Against this context, the broader US equity environment after the Nasdaq’s recent 1.76% gain, as reported by Scanx.trade for September 17, 2026, will also shape sentiment toward growth and healthcare names like Revvity today.